Argenx
ARGX
#402
Rank
โ‚น5.394 T
Marketcap
โ‚น85,785
Share price
-1.73%
Change (1 day)
4.20%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น2,062

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น2,072. In 2025 the company made an earnings per share (EPS) of โ‚น1,953 an increase over its 2024 EPS that were of โ‚น1,290.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น2,0625.54%
2025โ‚น1,95351.44%
2024โ‚น1,290-369.77%
2023-โ‚น478.18-60.46%
2022-โ‚น1,20963.33%
2021-โ‚น740.43-40.37%
2020-โ‚น1,242183.47%
2019-โ‚น438.06123.09%
2018-โ‚น196.3754.93%
2017-โ‚น126.7414.07%
2016-โ‚น111.1113.05%
2015-โ‚น98.28-36.34%
2014-โ‚น154.38209.04%
2013-โ‚น49.96-33.99%
2012-โ‚น75.68185.59%
2011-โ‚น26.50